|
|
.
See Category: Injury, poisoning and certain other consequences of external causes
ICD-10 (CM) Code and Descriptor
|
T85.41XA |
Breakdown (mechanical) of breast prosthesis and implant, initial encounter
|
T8541XA utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 10 |
ICD10
Position 11 |
| 51.35%
|
25.51%
|
12.84%
|
3.72%
|
2.70%
|
1.52%
|
0.84%
|
0.68%
|
0.51%
|
0.17%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for T85.41XA*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J3010
|
FENTANYL CITRATE INJECTION |
192
|
4,874
|
|
J2405
|
ONDANSETRON HCL INJECTION |
176
|
792
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
175
|
788
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
173
|
5,758
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
151
|
1,118
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
133
|
1,191
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
108
|
236
|
|
J7120
|
RINGERS LACTATE INFUSION |
93
|
140
|
|
88300
|
SURGICAL PATH GROSS |
92
|
121
|
|
19342
|
INSJ/RPLCMT BRST IMPLT SEP D |
92
|
92
|
|
88304
|
TISSUE EXAM BY PATHOLOGIST |
91
|
117
|
|
C1789
|
PROSTHESIS, BREAST, IMP |
88
|
143
|
|
J1170
|
HYDROMORPHONE INJECTION |
84
|
114
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
75
|
162
|
|
19330
|
RMVL RUPTURED BREAST IMPLANT |
73
|
73
|
|
J1580
|
GARAMYCIN GENTAMICIN INJ |
71
|
119
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
66
|
97
|
|
19371
|
PERI-IMPLT CAPSLC BRST COMPL |
61
|
61
|
|
J2001
|
LIDOCAINE INJECTION |
57
|
486
|
|
J0131
|
INJ, ACETAMINOPHEN (NOS) |
47
|
4,603
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
T85.41XA related to the following DRG Codes:
600-601
|
